HOME >> BIOLOGY >> NEWS
Scientists identify switch for brain's natural anti-oxidant defense

BOSTON--Scientists at Dana-Farber Cancer Institute report they have found how the brain turns on a system designed to protect its nerve cells from toxic "free radicals," a waste product of cell metabolism that has been implicated in some degenerative brain diseases, heart attacks, strokes, cancer, and aging.

Potentially, the researchers say, it may be possible to use drugs to strengthen the anti-oxidant system in the brain as a treatment for presently incurable diseases like Parkinson's, Huntington's, and Alzheimer's and possibly other maladies.

Dana-Farber's Bruce Spiegelman, PhD, and colleagues, using a mouse model, discovered that a regulatory protein, PGC-1a, switches on the anti-oxidant system when free radicals, or reactive oxygen species, begin to accumulate. It's believed that some brain diseases involve a failure of the protective system, and the authors report that turning on PGC-1a to high levels in cultured cells protected them against nerve toxins. The findings will be reported in the Oct. 20 issue of the journal Cell.

"This could have broad implications for the many diseases in which reactive oxygen species are implicated," said Spiegelman. Anti-oxidant supplements have been used with some success in patients with neurodegenerative diseases, but Spiegelman noted that the process sparked by PGC-1a "is how nature does it."

Researchers currently are screening drugs in search of compounds that could spur PGC-1a expression in brain cells, as well as exploring whether any harmful side effects might result. PGC-1a is a transcriptional co-activator discovered in Spiegelman's Dana-Farber laboratory in 1998. It has subsequently been found to play a master regulatory role in metabolic processes and muscle function, as well as being a culprit in diabetes.

The report establishes for the first time that PGC-1a both drives the mitochondria to make energy and triggers the cleanup of toxic free radicals that accumulate in
'"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
19-Oct-2006


Page: 1 2 3

Related biology news :

1. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
2. Scientists prove that disputed Korean stem cell line comes from an unfertilized egg and not cloning
3. Scientists move closer to bio-engineered bladders
4. Scientists find stem cell switch
5. Scientists discover new way to study nanostructures
6. Scientists a step closer to understanding how anaesthetics work in the brain
7. Scientists to make news at Computational Biology Conference
8. Accident-prone? Scientists link brain function to knee injuries
9. Scientists take next step in understanding potential target for ovarian cancer treatment
10. Scientists find brown fat master switch
11. Scientists identify 2 distinct Parkinsons networks

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/13/2018)... ... 13, 2018 , ... Fluence Bioengineering today unveiled the new ... is well suited for sole-source and supplemental lighting applications addressing virtually every cultivation ... an all-purpose light which can be adapted to virtually any setting, VYPR 2 ...
(Date:11/13/2018)... ... 2018 , ... Board-certified periodontist Dr. Jin Y. Kim, with two locations in ... Santa Ana, CA and surrounding areas, who want to explore permanent, long-term replacement options ... regularly helps patients get the advantages that come with All-on-4® dental implants ...
(Date:11/9/2018)... (PRWEB) , ... November 08, 2018 , ... ... advanced touch screen control. Heating blocks, also known as dry bath incubators are ... of tubes and containers. , For the new heating blocks, Boekel Scientific ...
Breaking Biology News(10 mins):
(Date:11/6/2018)... ... November 06, 2018 , ... ... for clinical trial data collection and management. TrialKit ™, an eClinical platform, ... generation devices can quickly and easily sign in to the app via facial ...
(Date:11/3/2018)... ... November 01, 2018 , ... Come to ... Jean Mulinde, Senior Advisor, Division of Clinical Compliance Evaluation, CDER, FDA will be ... data reliability. , What should clinical research industry stakeholders keep in mind when ...
(Date:10/31/2018)... ... October 30, 2018 , ... The assessment ... very important aspect of experimental biology. Reproducibility of cell-based assays is one of ... choosing the appropriate assay type, there are many more factors to be considered ...
(Date:10/24/2018)... ... 22, 2018 , ... uBiome, the leader in microbial genomics, ... Institute, Stephenson Chair of Data Science, and Professor in the Department of Biomedical ... scientists and doctors from around the world, Dr. Bourne will bring to uBiome ...
Breaking Biology Technology:
Cached News: